West Pharmaceutical Services Inc financial data

Symbol
WST on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
530 Herman O. West Drive, Exton, Pennsylvania
State of incorporation
Pennsylvania
Fiscal year end
December 31
Former names
WEST CO INC (to 2/11/1999)
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 285 % -22.8%
Quick Ratio 69 % -19.1%
Debt-to-equity 33.3 % -2.43%
Return On Assets 14.3 % -1.24%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.5M shares -1.79%
Common Stock, Shares, Outstanding 72.6M shares -1.76%
Entity Public Float 28.2B USD +26.5%
Common Stock, Value, Issued 18.8M USD 0%
Weighted Average Number of Shares Outstanding, Basic 73M shares -1.75%
Weighted Average Number of Shares Outstanding, Diluted 73.7M shares -2.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 695M USD -2.96%
Revenue from Contract with Customer, Excluding Assessed Tax 2.88B USD +0.38%
Research and Development Expense 69.9M USD +10.8%
Operating Income (Loss) 587M USD -10.2%
Nonoperating Income (Expense) 24.1M USD +4.17%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 129M USD -30.4%
Income Tax Expense (Benefit) 102M USD -5.11%
Net Income (Loss) Attributable to Parent 525M USD +1.2%
Earnings Per Share, Basic 7.11 USD/shares +2.16%
Earnings Per Share, Diluted 7.03 USD/shares +2.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 446M USD -44%
Accounts Receivable, after Allowance for Credit Loss, Current 479M USD -10.3%
Inventory, Net 419M USD -6.72%
Other Assets, Current 138M USD +46.9%
Assets, Current 1.48B USD -20.9%
Deferred Income Tax Assets, Net 33.9M USD -49.4%
Property, Plant and Equipment, Net 1.49B USD +18.4%
Operating Lease, Right-of-Use Asset 110M USD +11.2%
Intangible Assets, Net (Excluding Goodwill) 12.9M USD -23.2%
Goodwill 107M USD -0.65%
Other Assets, Noncurrent 50.1M USD +24.3%
Assets 3.49B USD -4.91%
Accounts Payable, Current 212M USD -2.89%
Liabilities, Current 634M USD +23.9%
Deferred Income Tax Liabilities, Net 13.7M USD -11%
Operating Lease, Liability, Noncurrent 84.6M USD -3.09%
Other Liabilities, Noncurrent 63.1M USD +14.5%
Liabilities 913M USD -1.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax -217M USD -18.2%
Retained Earnings (Accumulated Deficit) 3.72B USD +14.3%
Stockholders' Equity Attributable to Parent 2.58B USD -6.19%
Liabilities and Equity 3.49B USD -4.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 118M USD -14.4%
Net Cash Provided by (Used in) Financing Activities -271M USD -282%
Net Cash Provided by (Used in) Investing Activities -90.6M USD -10.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 75.3M shares 0%
Common Stock, Par or Stated Value Per Share 0.25 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -252M USD -3051%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 446M USD -44%
Deferred Tax Assets, Valuation Allowance 15.5M USD +16.5%
Operating Lease, Liability 105M USD +1.35%
Depreciation 34.7M USD +13%
Payments to Acquire Property, Plant, and Equipment 90.6M USD +10.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 492M USD -15.4%
Lessee, Operating Lease, Liability, to be Paid 120M USD 0%
Property, Plant and Equipment, Gross 2.86B USD +12.6%
Operating Lease, Liability, Current 20.3M USD +25.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19.8M USD +18.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.7M USD +22%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +30.3%
Deferred Income Tax Expense (Benefit) -8M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 15M USD -8.54%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.3M USD +10.9%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD -2.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3M shares 0%
Unrecognized Tax Benefits 38.8M USD +6.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.8M USD +46.8%
Operating Lease, Payments 29.5M USD +74.6%
Additional Paid in Capital 33.5M USD -78.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 200K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 98.2M USD -24.9%
Share-based Payment Arrangement, Expense 16.6M USD -42.2%
Interest Expense 8.4M USD +6.33%